New research suggests that spinal and hip fractures may double the risk of chronic widespread pain
The number of prescriptions for drugs for Alzheimer’s disease rose more than six-fold over the past decade
The European Commission recently approved two new indications for ramucirumab (Cyramza)
NICE has published nine quality standards covering GORD in children and young people
Actavis has reduced the list price of Reltebon (oxycodone hydrochloride) prolonged-release tablets
Improving oral health may prevent cardiovascular events and breast cancer – and even save lives
High urate levels protect against Parkinson’s disease in men, new research suggests
Reminder text messages improve blood pressure control and adherence with antihypertensives
Entresto (sacubitril plus valsartan) is now available for adults with symptomatic chronic heart failure.
Using antidepressants during pregnancy is associated with an increased risk of autism spectrum diseases
Polypharmacy and other factors associated with increased risks of hospitalisation among nursing home residents
Premenstrual syndrome might increase the risk of hypertension according to a new analysis
Infection with hepatitis C may increase the risk of developing Parkinson’s disease
Could technology prove to be the missing piece in the great diabetes malady jigsaw?
Clinical evidence now offers “strong support” to reduce systolic blood pressure to less than 130mmHg
Data suggests pharmacists in Scotland’s National Naloxone Programme are reducing opioid-related deaths
Poor adherence to statins may increase ischaemic stroke risk, according to a new study
A new study reveals that inequalities in anti-dementia drug (ADD) prescribing persist in England
The Scottish Medicines Consortium has accepted Trulicity (dulaglutide) for use in NHS Scotland.
Chondroitin sulphate reduces long-term progression of knee osteoarthritis more effectively than celecoxib?